Genticyn 80mg Injection contains Gentamicin sulfate, an aminoglycoside antibiotic effective against a broad spectrum of aerobic gram-negative and some gram-positive bacteria. It is indicated for the treatment of serious infections caused by susceptible strains, including septicemia, respiratory tract infections, urinary tract infections, intra-abdominal infections, bone and joint infections, skin and soft tissue infections, and endocarditis. Genticyn exerts its bactericidal action by binding irreversibly to the 30S ribosomal subunit, inhibiting bacterial protein synthesis and leading to cell death. The 80mg dosage is typically administered via intramuscular or intravenous injection, with dosing frequency and duration tailored according to the severity of infection, renal function, and patient response. Caution is advised in patients with renal impairment due to the risk of accumulation and nephrotoxicity. Monitoring of serum drug levels is recommended to optimize therapeutic efficacy while minimizing ototoxicity and nephrotoxicity. Genticyn should be used under strict medical supervision, avoiding concurrent use with other nephrotoxic or ototoxic agents. Hypersensitivity to aminoglycosides contraindicates its use. Proper hydration and renal function assessment are essential during therapy. Genticyn 80mg Injection is a potent antimicrobial agent reserved for serious infections where alternative treatments are not suitable or effective.